Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Capital Employed (2016 - 2026)

Pharma-Bio Serv's Return on Capital Employed history spans 14 years, with the latest figure at 0.06% for Q1 2026.

  • For Q1 2026, Return on Capital Employed rose 1.0% year-over-year to 0.06%; the TTM value through Jan 2026 reached 0.06%, up 1.0%, while the annual FY2025 figure was 0.05%, 3.0% up from the prior year.
  • Return on Capital Employed reached 0.06% in Q1 2026 per PBSV's latest filing, down from 0.05% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.08% in Q3 2023 to a low of 0.21% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.04%, with a median of 0.05% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: dropped -27bps in 2022, then increased 29bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.06% in 2022, then fell by -3bps to 0.06% in 2023, then crashed by -243bps to 0.09% in 2024, then soared by 40bps to 0.05% in 2025, then fell by -16bps to 0.06% in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Return on Capital Employed are 0.06% (Q1 2026), 0.05% (Q4 2025), and 0.05% (Q3 2025).